TGFβ (Transforming Growth Factor-Beta)-Activated Kinase 1 Regulates Arteriovenous Fistula Maturation

Area of Science:

• Vascular Biology
• Biomedical Engineering
• Regenerative Medicine

Background:

• Arteriovenous fistulae (AVF) are essential for hemodialysis but frequently fail to mature.
• Successful AVF maturation involves wall thickening and lumen dilation, dependent on extracellular matrix deposition.
• Transforming growth factor-beta-activated kinase 1 (TAK1) is implicated in regulating extracellular matrix production.

Purpose of the Study:

• To investigate the role of TAK1 in arteriovenous fistula (AVF) maturation.
• To determine if TAK1 regulates wall thickening and lumen dilation during AVF development.

Main Methods:

• Immunohistochemical analysis of TAK1, JNK, p38, collagen 1, and fibronectin in human and mouse AVF.
• In vivo manipulation of TAK1 function in a mouse AVF model.
• Assessment of AVF wall thickness and luminal diameter.
• Investigation of noncanonical TGFβ signaling activation by laminar shear stress in endothelial cells.

Main Results:

• TAK1, JNK, p38, collagen 1, and fibronectin expression were significantly elevated in AVF compared to control veins.
• Modulating TAK1 in vivo directly affected AVF wall thickness and luminal diameter.
• Reduced TAK1 function led to decreased thickness and diameter, while activation increased both.
• Arterial shear stress activated noncanonical TGFβ signaling, including TAK1 phosphorylation, in mouse endothelial cells.

Conclusions:

• TAK1 expression is upregulated in arteriovenous fistulae (AVF).
• TAK1 activity is a key regulator of AVF wall thickening and lumen diameter.
• Targeting noncanonical TGFβ signaling via TAK1 presents a potential therapeutic strategy to enhance AVF maturation.